Posted by MKB on November 18, 2004, at 8:21:12
In reply to Re: effexor side effects and suing » Racer, posted by MKB on November 18, 2004, at 7:56:28
I misquoted the Wyeth website. Here is the paragraph from their corporate site.
"EFFEXOR, Wyeth's SNRI (serotonin-norepinephrine reuptake inhibitor) antidepressant achieved worldwide net revenue of $893 million for the third quarter, an increase of 38%. This solid performance continues to be driven by strong clinical data supporting its use in depression and anxiety and its established therapeutic profile with prescribers. Effexor XR remains the first and only once-daily SNRI proven effective in the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder and the long-term prevention of relapse and recurrence of depression. The Effexor franchise is on track to exceed its longstanding goal of $3 billion in annual net revenue in 2004. However, as growth in the antidepressant category is slowing, the growth in Effexor revenues in the 2004 third quarter and first nine months may not be sustained for the balance of the year."